Research, News & Discoveries

Join the next Lab-to-Table conversation, “Picturing Progress: Representation in Scientific Art” on Feb. 20 at 11:00 a.m. Read More

VIRAL will highlight the work and stories of the university’s international researcher community during its second annual symposium. The platform is for international students to discuss research and personal experiences. Read More

Combining deep mutagenesis and cryo-EM reveals new conformational state of a protein responsible for high-speed DNA replication. The research builds on growing theories of molecular evolution. Read More

Baris and Pollenz have been selected as the Danzo and Cohen Postdoctoral Scholars, respectively. Destination Biochemistry applications for the next cohort are due Thursday, Feb. 15. Read More

Stachowiak is recognized for a paradigm-shifting discovery in the field of membrane biophysics, demonstrating that proteins can induce membrane curvature solely through a surface-crowding mechanism. Her lab investigates the biophysical mechanisms that underlie the function of lipid membranes in cells and explores the opportunity of creating bio-inspired materials and systems that borrow these mechanisms. Read More

High school student Benjamin Gordon, former Marnett lab intern, has been named a top scholar in the Regeneron Science Talent Search 2024, the oldest science and math competition for high school seniors in the U.S. Read More

We extend congratulations to our many community members who were recently promoted or received new appointments. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More

The “Molecular Muse” exhibit is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program. The program was recently awarded a fourth year of funding from the Burroughs Wellcome Fund. Read More

Avenir Award funding from the National Institute on Drug Abuse recognizes research that represents “the future of addiction science.” Brown’s research is creating an AI-experiment feedback loop that will help optimize painkilling drugs to be less addictive. Read More

Phase I clinical trial of a drug was successfully completed at the Warren Center for Neuroscience Drug Discovery, with promise to treat Alzheimer’s and other neurodegenerative diseases. The compound, named VU319, is the first Vanderbilt end-to-end drug discovery effort related to memory loss, starting from the earliest basic science research through human clinical trials. Read More